Th9 Cells: Probable players in ulcerative colitis pathogenesis
T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of diff...
Saved in:
Published in | International reviews of immunology Vol. 37; no. 4; pp. 192 - 205 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
04.07.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 0883-0185 1563-5244 1563-5244 |
DOI | 10.1080/08830185.2018.1457659 |
Cover
Loading…
Abstract | T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of different subtypes of helper T cells are changed. Recent studies have confirmed the existence of a new subset of helper T lymphocytes called Th9. Naive T cells can differentiate into Th9 subtypes if they are exposed simultaneously by interleukin (IL) 4 and transforming growth factor β and also secondary activation of a complicated network of transcription factors such as interferon regulatory factor 4 (IRF4) and Smads which are essential for adequate induction of this phenotype. Th9 cells specifically produce interleukin 9 and their probable roles in promoting intestinal inflammation are being investigated in human subjects and experimental models of ulcerative colitis (UC). Recently, infiltration of Th9 cells, overexpression of IL-9, and certain genes associated with Th9 differentiation have been demonstrated in inflammatory microenvironment of UC. Intestinal oversecretion of IL-9 protein is likely to break down epithelial barriers and compromise tolerance to certain commensal microorganisms which leads to inflammation. Th9 pathogenicity has not yet been adequately explored in UC and they are far from being considered as inflammatory cells in this milieu, therefore precise understanding the role of these newly identified cells in particular their potential role in gut pathogenesis may enable us to develop novel therapeutic approaches for inflammatory bowel disease. So, this article tries to discuss the latest knowledge on the above-mentioned field. |
---|---|
AbstractList | T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of different subtypes of helper T cells are changed. Recent studies have confirmed the existence of a new subset of helper T lymphocytes called Th9. Naive T cells can differentiate into Th9 subtypes if they are exposed simultaneously by interleukin (IL) 4 and transforming growth factor β and also secondary activation of a complicated network of transcription factors such as interferon regulatory factor 4 (IRF4) and Smads which are essential for adequate induction of this phenotype. Th9 cells specifically produce interleukin 9 and their probable roles in promoting intestinal inflammation are being investigated in human subjects and experimental models of ulcerative colitis (UC). Recently, infiltration of Th9 cells, overexpression of IL-9, and certain genes associated with Th9 differentiation have been demonstrated in inflammatory microenvironment of UC. Intestinal oversecretion of IL-9 protein is likely to break down epithelial barriers and compromise tolerance to certain commensal microorganisms which leads to inflammation. Th9 pathogenicity has not yet been adequately explored in UC and they are far from being considered as inflammatory cells in this milieu, therefore precise understanding the role of these newly identified cells in particular their potential role in gut pathogenesis may enable us to develop novel therapeutic approaches for inflammatory bowel disease. So, this article tries to discuss the latest knowledge on the above-mentioned field. T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of different subtypes of helper T cells are changed. Recent studies have confirmed the existence of a new subset of helper T lymphocytes called Th9. Naive T cells can differentiate into Th9 subtypes if they are exposed simultaneously by interleukin (IL) 4 and transforming growth factor β and also secondary activation of a complicated network of transcription factors such as interferon regulatory factor 4 (IRF4) and Smads which are essential for adequate induction of this phenotype. Th9 cells specifically produce interleukin 9 and their probable roles in promoting intestinal inflammation are being investigated in human subjects and experimental models of ulcerative colitis (UC). Recently, infiltration of Th9 cells, overexpression of IL-9, and certain genes associated with Th9 differentiation have been demonstrated in inflammatory microenvironment of UC. Intestinal oversecretion of IL-9 protein is likely to break down epithelial barriers and compromise tolerance to certain commensal microorganisms which leads to inflammation. Th9 pathogenicity has not yet been adequately explored in UC and they are far from being considered as inflammatory cells in this milieu, therefore precise understanding the role of these newly identified cells in particular their potential role in gut pathogenesis may enable us to develop novel therapeutic approaches for inflammatory bowel disease. So, this article tries to discuss the latest knowledge on the above-mentioned field.T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of different subtypes of helper T cells are changed. Recent studies have confirmed the existence of a new subset of helper T lymphocytes called Th9. Naive T cells can differentiate into Th9 subtypes if they are exposed simultaneously by interleukin (IL) 4 and transforming growth factor β and also secondary activation of a complicated network of transcription factors such as interferon regulatory factor 4 (IRF4) and Smads which are essential for adequate induction of this phenotype. Th9 cells specifically produce interleukin 9 and their probable roles in promoting intestinal inflammation are being investigated in human subjects and experimental models of ulcerative colitis (UC). Recently, infiltration of Th9 cells, overexpression of IL-9, and certain genes associated with Th9 differentiation have been demonstrated in inflammatory microenvironment of UC. Intestinal oversecretion of IL-9 protein is likely to break down epithelial barriers and compromise tolerance to certain commensal microorganisms which leads to inflammation. Th9 pathogenicity has not yet been adequately explored in UC and they are far from being considered as inflammatory cells in this milieu, therefore precise understanding the role of these newly identified cells in particular their potential role in gut pathogenesis may enable us to develop novel therapeutic approaches for inflammatory bowel disease. So, this article tries to discuss the latest knowledge on the above-mentioned field. |
Author | Shohan, Mojtaba Elahi, Shokrollah Rafieian-Kopaei, Mahmoud Bagheri, Nader Soltani, Emad Shirzad, Hedayatollah |
Author_xml | – sequence: 1 givenname: Mojtaba surname: Shohan fullname: Shohan, Mojtaba organization: Department of Microbiology and Immunology, Faculty of Medicine, Shahrekord University of Medical Sciences – sequence: 2 givenname: Shokrollah surname: Elahi fullname: Elahi, Shokrollah organization: Department of Dentistry, Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta – sequence: 3 givenname: Hedayatollah surname: Shirzad fullname: Shirzad, Hedayatollah email: shirzad1951@yahoo.com organization: Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences – sequence: 4 givenname: Mahmoud orcidid: 0000-0003-3190-7863 surname: Rafieian-Kopaei fullname: Rafieian-Kopaei, Mahmoud organization: Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences – sequence: 5 givenname: Nader surname: Bagheri fullname: Bagheri, Nader organization: Department of Microbiology and Immunology, Faculty of Medicine, Shahrekord University of Medical Sciences – sequence: 6 givenname: Emad surname: Soltani fullname: Soltani, Emad organization: Department of Microbiology and Immunology, Faculty of Medicine, Shahrekord University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29672174$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkDFv2zAQhYkiRWKn-QktNGaRe6RIimyAIIXRJAUMtIM7ExR1ihnQokPKLfzvK8P2kiFZ7pbvvbv3puSsjz0S8pnCjIKCr6BUBVSJGRvnjHJRS6E_kAkVsioF4_yMTPZMuYcuyDTnZwBaCc3PyQXTsma05hNyu1zpYo4h5G_F7xQb2wQsNsHuMOXC98U2OEx28H-xcDH4wediY4dVfMIes8-fyMfOhoxXx31J_tz_WM4fy8Wvh5_z74vSVVIOZdVS0TgAB12jnHICZNMKqcBRK2stkTUWaqdbDg4VKMe7VmMHDfKOs4pVl-T64LtJ8WWLeTBrn934tu0xbrNhwJTmmjM1ol-O6LZZY2s2ya9t2plT5hG4OQAuxZwTdsb5YYwY-yFZHwwFs2_YnBo2-4bNseFRLV6pTwfe090ddL7vYlrbfzGF1gx2F2Lqku2dz6Z62-I_sBuRJw |
CitedBy_id | crossref_primary_10_1007_s11726_024_1424_6 crossref_primary_10_1016_j_jaci_2024_11_031 crossref_primary_10_1097_JCMA_0000000000000202 crossref_primary_10_1111_sji_13412 crossref_primary_10_1016_j_intimp_2024_112486 crossref_primary_10_1007_s43440_020_00213_z crossref_primary_10_3389_fphar_2022_1070184 crossref_primary_10_3390_ijms20081912 crossref_primary_10_3390_jcm11020400 crossref_primary_10_3390_ijms24032696 crossref_primary_10_1155_2020_6503539 crossref_primary_10_1080_08830185_2018_1499488 crossref_primary_10_1128_IAI_00014_21 crossref_primary_10_1002_iub_2295 |
Cites_doi | 10.1111/imr.12028 10.1078/0065-1281-00641 10.1038/ni.2390 10.1038/mi.2012.77 10.1016/j.immuni.2010.07.014 10.1016/j.cell.2006.02.017 10.4049/jimmunol.164.11.5549 10.1038/mi.2015.59 10.1002/eji.200939618 10.1016/j.immuni.2014.10.004 10.1016/S1074-7613(00)80439-2 10.4049/jimmunol.1000356 10.1016/j.immuni.2016.05.009 10.3389/fimmu.2016.00409 10.1158/1078-0432.CCR-05-1426 10.1074/jbc.M206473200 10.1038/ni.2303 10.1038/ni.1802 10.1084/jem.20090246 10.3748/wjg.v13.i22.3027 10.1016/j.it.2011.01.006 10.1371/journal.pone.0115195 10.1182/blood-2008-05-078154 10.1016/S0091-6749(99)70165-X 10.1038/ni.1659 10.4049/jimmunol.1200808 10.1111/j.1365-2567.2010.03332.x 10.1164/rccm.201211-2073OC 10.1016/j.bbrc.2015.11.057 10.1038/ncomms5575 10.1053/j.gastro.2006.04.020 10.4161/21688370.2014.983777 10.4049/jimmunol.1000986 10.1016/j.jneuroim.2010.06.002 10.1146/annurev-immunol-032713-120218 10.1371/journal.ppat.1003913 10.1016/j.micpath.2015.03.010 10.1155/2012/925135 10.1016/S0091-6749(00)90185-4 10.1016/j.coi.2012.01.014 10.1038/nature05010 10.1016/S0140-6736(07)60750-8 10.1016/j.micpath.2015.01.008 10.1016/j.arcmed.2016.07.013 10.1111/j.1582-4934.2001.tb00169.x 10.1016/j.jaci.2015.01.021 10.1152/ajpgi.00513.2005 10.1002/ibd.21709 10.1007/s11481-009-9186-y 10.4049/jimmunol.164.8.4197 10.1016/j.immuni.2012.08.024 10.1016/j.autrev.2016.02.020 10.1038/icb.2010.53 10.4049/jimmunol.0900085 10.1073/pnas.1006451107 10.5812/jjm.21701 10.1172/JCI69489 10.1038/ni.2920 10.1007/s00281-016-0600-2 10.1038/nri3299 10.1093/intimm/dxt039 10.1136/gut.2008.163667 10.1093/intimm/dxw006 10.1136/gut.2007.135053 10.1016/j.immuni.2013.07.020 10.1016/j.biocel.2012.05.003 10.1016/j.immuni.2011.07.010 10.1016/j.immuni.2013.01.007 10.1016/j.jaci.2009.09.054 10.4049/jimmunol.0901471 10.1111/cea.12787 10.4049/jimmunol.178.5.3244 10.1165/ajrcmb.19.5.3457 10.1126/science.1219328 10.1016/j.jaci.2013.09.049 10.1155/2014/781649 10.1111/j.1749-6632.2011.06351.x 10.1016/j.cytogfr.2017.07.004 10.1016/j.micpath.2013.12.006 10.1038/nrgastro.2014.201 10.1126/science.1198469 10.1038/nri2653 10.3892/mmr.2013.1258 10.1172/JCI65459 10.1007/s12026-014-8540-1 10.1016/j.cell.2011.09.025 10.1016/j.it.2013.10.004 10.1007/s00281-016-0611-z 10.4049/jimmunol.166.7.4391 10.1073/pnas.0812530106 10.1111/j.1365-2567.2012.03612.x 10.1016/j.cyto.2015.10.008 10.1136/gutjnl-2013-305947 10.1016/j.immuni.2012.01.020 10.1002/eji.201242825 10.1074/jbc.274.36.25855 10.1016/j.jaci.2005.03.011 10.1002/ibd.21248 10.4049/jimmunol.165.4.1847 10.1164/rccm.2105079 10.1038/nature11225 10.1016/j.cytogfr.2013.09.001 10.1128/MCB.16.9.4710 10.4049/jimmunol.0900363 10.1038/nature07674 10.1038/ni1500 10.1016/j.jaci.2016.01.055 10.1007/BF00204898 10.1155/2015/895416 10.1016/j.ajpath.2012.03.044 10.4049/jimmunol.174.6.3237 10.1074/jbc.273.15.9255 10.1016/j.immuni.2015.08.020 10.1016/j.cytogfr.2016.02.002 10.1111/imr.12634 10.1016/j.cyto.2004.01.006 10.1038/ni.1867 10.4049/jimmunol.0801941 10.1164/ajrccm.153.4.8616554 10.1016/j.coi.2012.02.001 10.1016/S0171-2985(11)80414-6 10.1038/s41598-017-02422-8 10.4049/jimmunol.1303184 10.3109/08820139.2015.1122615 10.4049/jimmunol.1203420 10.1007/s00281-016-0606-9 10.4049/jimmunol.1003049 10.1038/s41467-017-00674-6 10.4049/jimmunol.1301276 10.1073/pnas.0809077106 10.1165/rcmb.2002-0207OC 10.1073/pnas.1301138111 10.1038/nri2848 10.4049/jimmunol.1502383 10.1186/1465-9921-6-33 10.1002/eji.201646846 10.4049/jimmunol.0901906 10.1136/gutjnl-2012-303955 10.1111/j.1365-3083.2010.02432.x 10.1038/sj.ejhg.5200541 10.1038/nri2785 10.1002/cyto.a.22348 10.1067/mai.2003.1485 10.1038/ni.3489 10.1016/j.meegid.2018.02.020 10.1016/j.micpath.2017.06.040 10.1007/978-94-017-9487-9_8 |
ContentType | Journal Article |
Copyright | 2018 Taylor & Francis 2018 |
Copyright_xml | – notice: 2018 Taylor & Francis 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1080/08830185.2018.1457659 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1563-5244 |
EndPage | 205 |
ExternalDocumentID | 29672174 10_1080_08830185_2018_1457659 1457659 |
Genre | Review Journal Article |
GroupedDBID | --- 00X 03L 0BK 0R~ 29J 36B 4.4 53G 5GY AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABJNI ABLIJ ABLKL ABUPF ABXYU ACENM ACGEJ ACGFS ACIEZ ACUHS ADCVX ADRBQ ADXPE AECIN AENEX AEOZL AFKVX AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P H13 HZ~ KRBQP KSSTO KWAYT KYCEM M4Z O9- P2P RNANH RVRKI SV3 TBQAZ TDBHL TERGH TFDNU TFW TUROJ TUS UEQFS UHWXJ V1S AAGDL AAYXX ABWVI ADYSH AFRVT AMPGV CITATION 0VX 5VS AALIY AAORF ABWCV ABZEW ACKZS ACOPL ADFOM ADFZZ AEIIZ AFLEI AJVHN AWYRJ BRMBE CAG CGR COF CUY CVF CYYVM CZDIS DRXRE DWTOO ECM EIF JENTW LJTGL M44 NPM NUSFT QQXMO 7X8 TASJS |
ID | FETCH-LOGICAL-c366t-3d15bc00c0fb8c8c506bd5680c1a6796e2ba07c9d40ce808c4fd9ef0be4f42323 |
ISSN | 0883-0185 1563-5244 |
IngestDate | Fri Sep 05 05:58:52 EDT 2025 Thu Apr 03 07:06:43 EDT 2025 Thu Apr 24 22:56:34 EDT 2025 Tue Jul 01 00:24:17 EDT 2025 Wed Dec 25 09:08:52 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Intestinal inflammation ulcerative colitis Th9 IL-9 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c366t-3d15bc00c0fb8c8c506bd5680c1a6796e2ba07c9d40ce808c4fd9ef0be4f42323 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3190-7863 |
PMID | 29672174 |
PQID | 2028949428 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | pubmed_primary_29672174 crossref_citationtrail_10_1080_08830185_2018_1457659 informaworld_taylorfrancis_310_1080_08830185_2018_1457659 proquest_miscellaneous_2028949428 crossref_primary_10_1080_08830185_2018_1457659 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-07-04 |
PublicationDateYYYYMMDD | 2018-07-04 |
PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | International reviews of immunology |
PublicationTitleAlternate | Int Rev Immunol |
PublicationYear | 2018 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | cit0077 cit0110 cit0078 cit0111 cit0075 cit0076 cit0073 cit0074 cit0071 cit0072 cit0070 cit0118 cit0119 cit0116 cit0117 cit0114 cit0115 cit0079 cit0112 cit0113 cit0066 cit0067 cit0100 cit0064 cit0065 cit0062 cit0063 cit0060 cit0061 cit0109 cit0107 cit0108 Zundler S (cit0155) 2016 cit0105 cit0106 cit0103 cit0104 cit0068 cit0101 cit0069 cit0102 cit0011 cit0099 cit0132 cit0012 cit0133 cit0097 cit0130 cit0010 cit0098 cit0131 cit0095 cit0096 cit0093 Shirzad H (cit0144) 2015; 78 cit0094 cit0091 cit0092 cit0090 cit0019 cit0017 cit0138 cit0018 cit0139 cit0015 cit0136 cit0016 cit0013 cit0134 cit0014 cit0135 cit0088 cit0121 cit0001 cit0089 cit0122 cit0086 cit0087 cit0120 cit0084 cit0085 cit0082 cit0083 cit0080 cit0081 cit0008 cit0129 cit0009 cit0006 cit0127 cit0007 cit0128 cit0004 cit0125 cit0005 cit0126 cit0002 cit0123 cit0003 cit0124 cit0033 cit0154 cit0034 cit0031 cit0152 cit0032 cit0153 cit0150 cit0030 cit0151 cit0039 cit0037 cit0038 cit0035 cit0036 cit0022 cit0143 cit0023 cit0020 cit0141 cit0021 cit0142 cit0140 cit0028 cit0149 cit0029 cit0026 cit0147 cit0027 cit0148 cit0024 cit0145 cit0025 cit0146 cit0055 cit0056 cit0053 cit0054 Silverberg MS (cit0137) 2005; 19 cit0051 cit0052 cit0050 cit0059 cit0057 cit0058 cit0044 cit0045 cit0042 cit0043 cit0040 cit0041 cit0048 cit0049 cit0046 cit0047 |
References_xml | – ident: cit0033 doi: 10.1111/imr.12028 – ident: cit0053 doi: 10.1078/0065-1281-00641 – ident: cit0096 doi: 10.1038/ni.2390 – ident: cit0135 doi: 10.1038/mi.2012.77 – ident: cit0067 doi: 10.1016/j.immuni.2010.07.014 – ident: cit0121 doi: 10.1016/j.cell.2006.02.017 – ident: cit0050 doi: 10.4049/jimmunol.164.11.5549 – ident: cit0058 doi: 10.1038/mi.2015.59 – ident: cit0061 doi: 10.1002/eji.200939618 – ident: cit0020 doi: 10.1016/j.immuni.2014.10.004 – ident: cit0060 doi: 10.1016/S1074-7613(00)80439-2 – ident: cit0043 doi: 10.4049/jimmunol.1000356 – ident: cit0083 doi: 10.1016/j.immuni.2016.05.009 – ident: cit0118 doi: 10.3389/fimmu.2016.00409 – ident: cit0056 doi: 10.1158/1078-0432.CCR-05-1426 – ident: cit0131 doi: 10.1074/jbc.M206473200 – ident: cit0059 doi: 10.1038/ni.2303 – ident: cit0014 doi: 10.1038/ni.1802 – ident: cit0037 doi: 10.1084/jem.20090246 – ident: cit0052 doi: 10.3748/wjg.v13.i22.3027 – ident: cit0066 doi: 10.1016/j.it.2011.01.006 – ident: cit0116 doi: 10.1371/journal.pone.0115195 – ident: cit0001 doi: 10.1182/blood-2008-05-078154 – ident: cit0092 doi: 10.1016/S0091-6749(99)70165-X – ident: cit0031 doi: 10.1038/ni.1659 – ident: cit0086 doi: 10.4049/jimmunol.1200808 – ident: cit0106 doi: 10.1111/j.1365-2567.2010.03332.x – ident: cit0087 doi: 10.1164/rccm.201211-2073OC – ident: cit0139 doi: 10.1016/j.bbrc.2015.11.057 – ident: cit0076 doi: 10.1038/ncomms5575 – ident: cit0130 doi: 10.1053/j.gastro.2006.04.020 – ident: cit0005 doi: 10.4161/21688370.2014.983777 – ident: cit0082 doi: 10.1038/ncomms5575 – ident: cit0040 doi: 10.4049/jimmunol.1000986 – ident: cit0042 doi: 10.1016/j.jneuroim.2010.06.002 – ident: cit0104 doi: 10.1146/annurev-immunol-032713-120218 – ident: cit0103 doi: 10.1371/journal.ppat.1003913 – ident: cit0146 doi: 10.1016/j.micpath.2015.03.010 – ident: cit0002 doi: 10.1155/2012/925135 – ident: cit0100 doi: 10.1016/S0091-6749(00)90185-4 – ident: cit0011 doi: 10.1016/j.coi.2012.01.014 – ident: cit0044 doi: 10.1038/nature05010 – ident: cit0136 doi: 10.1016/S0140-6736(07)60750-8 – ident: cit0142 doi: 10.1016/j.micpath.2015.01.008 – ident: cit0143 doi: 10.1016/j.arcmed.2016.07.013 – ident: cit0129 doi: 10.1111/j.1582-4934.2001.tb00169.x – ident: cit0048 doi: 10.1016/j.jaci.2015.01.021 – ident: cit0151 doi: 10.1152/ajpgi.00513.2005 – ident: cit0123 doi: 10.1002/ibd.21709 – ident: cit0025 doi: 10.1038/ni.2303 – ident: cit0152 doi: 10.1007/s11481-009-9186-y – ident: cit0110 doi: 10.4049/jimmunol.164.8.4197 – ident: cit0012 doi: 10.1016/j.immuni.2012.08.024 – ident: cit0021 doi: 10.1016/j.autrev.2016.02.020 – ident: cit0078 doi: 10.1038/icb.2010.53 – ident: cit0109 doi: 10.4049/jimmunol.0900085 – ident: cit0128 doi: 10.1073/pnas.1006451107 – ident: cit0148 doi: 10.5812/jjm.21701 – ident: cit0079 doi: 10.1172/JCI69489 – ident: cit0006 doi: 10.1038/ni.2920 – ident: cit0063 doi: 10.1007/s00281-016-0600-2 – ident: cit0127 doi: 10.1038/nri3299 – ident: cit0023 doi: 10.1093/intimm/dxt039 – ident: cit0150 doi: 10.1136/gut.2008.163667 – ident: cit0003 doi: 10.1093/intimm/dxw006 – ident: cit0149 doi: 10.1136/gut.2007.135053 – ident: cit0112 doi: 10.1016/j.immuni.2013.07.020 – ident: cit0009 doi: 10.1016/j.biocel.2012.05.003 – ident: cit0008 doi: 10.1016/j.immuni.2011.07.010 – ident: cit0075 doi: 10.1016/j.immuni.2013.01.007 – ident: cit0094 doi: 10.1016/j.jaci.2015.01.021 – ident: cit0036 doi: 10.1016/j.jaci.2009.09.054 – ident: cit0055 doi: 10.4049/jimmunol.0901471 – ident: cit0119 doi: 10.1111/cea.12787 – ident: cit0035 doi: 10.4049/jimmunol.178.5.3244 – ident: cit0093 doi: 10.1165/ajrcmb.19.5.3457 – ident: cit0132 doi: 10.1126/science.1219328 – ident: cit0097 doi: 10.1016/j.jaci.2013.09.049 – ident: cit0113 doi: 10.1155/2014/781649 – volume: 78 year: 2015 ident: cit0144 publication-title: Acta Gastroenterol Belg. – ident: cit0030 doi: 10.1111/j.1749-6632.2011.06351.x – ident: cit0024 doi: 10.1016/j.cytogfr.2017.07.004 – ident: cit0140 doi: 10.1016/j.micpath.2013.12.006 – ident: cit0134 doi: 10.1038/nrgastro.2014.201 – ident: cit0122 doi: 10.1126/science.1198469 – ident: cit0007 doi: 10.1038/nri2653 – ident: cit0154 doi: 10.3892/mmr.2013.1258 – ident: cit0016 doi: 10.1172/JCI65459 – ident: cit0117 doi: 10.1007/s12026-014-8540-1 – ident: cit0125 doi: 10.1016/j.cell.2011.09.025 – ident: cit0084 doi: 10.1172/JCI65459 – ident: cit0071 doi: 10.1016/j.it.2013.10.004 – ident: cit0105 doi: 10.1007/s00281-016-0611-z – ident: cit0049 doi: 10.4049/jimmunol.166.7.4391 – ident: cit0038 doi: 10.1073/pnas.0812530106 – ident: cit0133 doi: 10.1111/j.1365-2567.2012.03612.x – ident: cit0138 doi: 10.1016/j.cyto.2015.10.008 – ident: cit0072 doi: 10.1136/gutjnl-2013-305947 – ident: cit0077 doi: 10.1016/j.immuni.2012.01.020 – ident: cit0095 doi: 10.1002/eji.201242825 – ident: cit0028 doi: 10.1074/jbc.274.36.25855 – ident: cit0102 doi: 10.1016/j.jaci.2005.03.011 – ident: cit0153 doi: 10.1002/ibd.21248 – ident: cit0054 doi: 10.4049/jimmunol.165.4.1847 – ident: cit0098 doi: 10.1164/rccm.2105079 – ident: cit0126 doi: 10.1038/nature11225 – ident: cit0018 doi: 10.1016/j.cytogfr.2013.09.001 – ident: cit0027 doi: 10.1128/MCB.16.9.4710 – ident: cit0073 doi: 10.4049/jimmunol.0900363 – ident: cit0069 doi: 10.1038/nature07674 – ident: cit0070 doi: 10.1038/ni1500 – ident: cit0108 doi: 10.1016/j.jaci.2016.01.055 – ident: cit0029 doi: 10.1007/BF00204898 – ident: cit0107 doi: 10.1155/2015/895416 – ident: cit0019 doi: 10.1016/j.ajpath.2012.03.044 – ident: cit0124 doi: 10.4049/jimmunol.174.6.3237 – ident: cit0026 doi: 10.1074/jbc.273.15.9255 – ident: cit0047 doi: 10.1016/j.immuni.2015.08.020 – ident: cit0088 doi: 10.1016/j.cytogfr.2016.02.002 – ident: cit0045 doi: 10.1111/imr.12634 – ident: cit0051 doi: 10.1016/j.cyto.2004.01.006 – ident: cit0017 doi: 10.1038/ni.1867 – ident: cit0099 doi: 10.4049/jimmunol.0801941 – ident: cit0089 doi: 10.1164/ajrccm.153.4.8616554 – ident: cit0004 doi: 10.1016/j.coi.2012.02.001 – ident: cit0032 doi: 10.1016/S0171-2985(11)80414-6 – ident: cit0115 doi: 10.1038/s41598-017-02422-8 – ident: cit0065 doi: 10.4049/jimmunol.1303184 – ident: cit0145 doi: 10.3109/08820139.2015.1122615 – ident: cit0046 doi: 10.4049/jimmunol.1203420 – ident: cit0114 doi: 10.1007/s00281-016-0606-9 – ident: cit0022 doi: 10.4049/jimmunol.1003049 – ident: cit0081 doi: 10.1038/s41467-017-00674-6 – ident: cit0074 doi: 10.4049/jimmunol.1301276 – year: 2016 ident: cit0155 publication-title: Gut. – ident: cit0068 doi: 10.1073/pnas.0809077106 – ident: cit0091 doi: 10.1165/rcmb.2002-0207OC – ident: cit0085 doi: 10.1073/pnas.1301138111 – ident: cit0039 doi: 10.1038/nri2848 – ident: cit0064 doi: 10.4049/jimmunol.1502383 – ident: cit0034 doi: 10.1186/1465-9921-6-33 – ident: cit0080 doi: 10.1002/eji.201646846 – ident: cit0041 doi: 10.4049/jimmunol.0901906 – ident: cit0120 doi: 10.1136/gutjnl-2012-303955 – ident: cit0015 doi: 10.1111/j.1365-3083.2010.02432.x – ident: cit0090 doi: 10.1038/sj.ejhg.5200541 – ident: cit0010 doi: 10.1038/nri2785 – ident: cit0062 doi: 10.1002/cyto.a.22348 – ident: cit0101 doi: 10.1067/mai.2003.1485 – ident: cit0057 doi: 10.1038/ni.3489 – ident: cit0147 doi: 10.1016/j.meegid.2018.02.020 – ident: cit0141 doi: 10.1016/j.micpath.2017.06.040 – ident: cit0013 doi: 10.1007/978-94-017-9487-9_8 – ident: cit0111 doi: 10.1111/cea.12787 – volume: 19 start-page: 5A year: 2005 ident: cit0137 publication-title: Can J Gastroenterol Hepatol. |
SSID | ssj0013594 |
Score | 2.2557325 |
SecondaryResourceType | review_article |
Snippet | T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 192 |
SubjectTerms | Cell Differentiation - immunology Colitis, Ulcerative - immunology Colitis, Ulcerative - pathology Colon - immunology Colon - metabolism Colon - microbiology Colon - pathology Gastrointestinal Microbiome - immunology Humans IL-9 Immune Tolerance - immunology Interferon Regulatory Factors - immunology Interferon Regulatory Factors - metabolism Interleukin-4 - immunology Interleukin-4 - metabolism Interleukin-9 - immunology Interleukin-9 - metabolism Intestinal inflammation Intestinal Mucosa - immunology Intestinal Mucosa - metabolism Intestinal Mucosa - microbiology Intestinal Mucosa - pathology Signal Transduction - immunology Smad Proteins - immunology Smad Proteins - metabolism T-Lymphocyte Subsets - immunology T-Lymphocyte Subsets - metabolism T-Lymphocytes, Helper-Inducer - immunology T-Lymphocytes, Helper-Inducer - metabolism Th9 Transforming Growth Factor beta - immunology Transforming Growth Factor beta - metabolism ulcerative colitis |
Title | Th9 Cells: Probable players in ulcerative colitis pathogenesis |
URI | https://www.tandfonline.com/doi/abs/10.1080/08830185.2018.1457659 https://www.ncbi.nlm.nih.gov/pubmed/29672174 https://www.proquest.com/docview/2028949428 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BK1AvCMorvGQkbpWjtb221xyQ2pIogqYgSKTcrH0Zh5q4SpxD--uZfSRxRFALFyvaeBJr5_No5_UNQu8kw1mogsIPZch8QiX1aUKkr9KEFYFigTAZ_OF5MhiTT5N4sikbM90lDe-K6519Jf-jVVgDveou2X_Q7PpHYQE-g37hChqG6y11nB2dqqoyZW1f5_Bq6j6oy4rpc7SOZCwroRy1tzCFbgtNpFrWP7SFmy7aJ9Pt0KAjKTWEErqDZCv4_r2sSxs3HdY_G8bXlr1XMTMj-AjuuJhrhJUbmen82sJpoCS7Al-__fU3VkwVINX_DE68mtouovJXvZTtsERATQkraVvSJAIv15I7dtWONWd-LeeLgxlp2dLADsn7w8a7okhKwTbRWFfnUbD34Dc5avEtTu3zL3l_fHaWj3qT0V20H6apTubvH598POlvsk2xGZi5frxVp5fmYN_1N1tnmC2G27_7Kea8MnqIHjhHwzu2qHmE7qjZIbpnR49eHaL7Q1dU8Rh9ABh5BkbvvRWIPAcibzrzNiDyHIi8NoieoHG_Nzod-G6shi-iJGn8SAYxFxgLXHAqqIhxwmWcUCwCpqOKKuQMpyKTBAtFMRWkkJkqMFek0Gn96Cnam9Uz9Rx5rOCcxzyUNJYkKmLOQy5YihOZUZKxoIPIaqNy4Tjn9eiTKg9W1LRuf3O9v7nb3w7qrsUuLenKTQJZWwt5Y6JdhR1Nk0c3yL5dqSwH06rzZWym6uUC7gppRjJw0DvomdXl-nHCLEm1N__iFtIv0cHmDXmF9pr5Ur2Go2zD3zgk_gZpEJoi |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Th9+Cells%3A+Probable+players+in+ulcerative+colitis+pathogenesis&rft.jtitle=International+reviews+of+immunology&rft.au=Shohan%2C+Mojtaba&rft.au=Elahi%2C+Shokrollah&rft.au=Shirzad%2C+Hedayatollah&rft.au=Rafieian-Kopaei%2C+Mahmoud&rft.date=2018-07-04&rft.issn=1563-5244&rft.eissn=1563-5244&rft.volume=37&rft.issue=4&rft.spage=192&rft_id=info:doi/10.1080%2F08830185.2018.1457659&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0883-0185&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0883-0185&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0883-0185&client=summon |